Comorbid Behavioral Problems and Psychiatric Disorders in Autism Spectrum Disorders

2016 ◽  
Vol 02 (02) ◽  
Author(s):  
Cecilia Belardinelli ◽  
Mahreen Raza
Keyword(s):  
Autism Spectrum Disorders ◽  
Psychiatric Disorders ◽  
Behavioral Problems ◽  
Autism Spectrum ◽  
Spectrum Disorders

scholarly journals SOCIAL STATUS AND GUT MICROBIAL DYSBIOSIS IN ADULTS AND CHILDREN WITH AUTISM SPECTRUM DISORDERS: A PROFOUND REVIEW OF THE AVAILABLE LITERATURE SOURCES

2021 ◽  
Vol 27 (3) ◽  
pp. 3939-3946
Author(s):  
Sevginar Ibryamova ◽  
◽  
Veselin Petkov ◽  
Tsveteslava Ignatova-Ivanova ◽  
Georgi Kolev ◽  
...  
Keyword(s):  
Autism Spectrum Disorders ◽  
Behavioral Problems ◽  
Autism Spectrum ◽  
Repetitive Behaviors ◽  
Diagnostic Methods ◽  
Restricted Interests ◽  
Microbial Dysbiosis ◽  
Gastrointestinal Problems ◽  
Adults And Children ◽  
Spectrum Disorders

Autism is a complex disorder without a specific diagnosis, so the disease is defined by its specific characteristics described in the literature as cognitive defects, social, communication and behavioral problems, repetitive behaviors, unusual sensitivity to stimuli such as noise, restricted interests, and self stimulation. There are many models in the literature explaining the biology of autism, which are based on genetics, immunity, various environmental factors and diet. There is a lot of literature data that people with Autism Spectrum Disorders (ASD) often have gastrointestinal problems that also affect their behavior. ASD suffer developmental disabilities from an early age, which can be both physical and psychological. Often people suffer these problems even throughout their lives. This review aims to provide basic information on definitions, historical data, diagnostic methods, behavioral etiology, gastrointestinal and social problems in adults and children with ASD.

scholarly journals Child and parent outcomes following parent interventions for child emotional and behavioral problems in autism spectrum disorders: A systematic review and meta-analysis

Autism ◽  
2019 ◽  
Vol 23 (7) ◽  
pp. 1630-1644 ◽  
Author(s):  
Joanne Tarver ◽  
Melanie Palmer ◽  
Sophie Webb ◽  
Stephen Scott ◽  
Vicky Slonims ◽  
...  
Keyword(s):  
Autism Spectrum Disorders ◽  
Child Behavior ◽  
Behavioral Problems ◽  
Well Being ◽  
Autism Spectrum ◽  
Mean Difference ◽  
Emotional And Behavioral Problems ◽  
Standardized Mean Difference ◽  
Spectrum Disorders ◽  
Parent Interventions

There is growing interest in the development of behavioral parent interventions targeting emotional and behavioral problems in children with autism spectrum disorders. Such interventions have potential to improve a number of child and parental well-being outcomes beyond disruptive child behavior. This systematic review and meta-analysis assesses evidence for the efficacy of behavioral parent interventions for disruptive and hyperactive child behavior in autism spectrum disorders, as well as parenting efficacy and stress. A total of 11 articles from nine randomized controlled trials were included. Sufficient data were available to calculate standardized mean difference and show favorable effects of behavioral parent interventions on parent-reported measures of child disruptive behavior (standardized mean difference = 0.67), hyperactivity (standardized mean difference = 0.31) and parent stress (standardized mean difference = 0.37); effects on parent efficacy are less clear (standardized mean difference = 0.39, p = 0.17). There were insufficient data to explore intervention effects on internalizing behavior in autism spectrum disorders, parenting behaviors, or observational and teacher-reported outcomes, providing important avenues for future research. This review adds to growing evidence of the efficacy of behavioral parent interventions for child behavior and parental well-being in autism spectrum disorders (Prospero: CRD42016033979).

Comorbid psychiatric disorders in Arab children with Autism spectrum disorders

2012 ◽  
Vol 6 (1) ◽  
pp. 240-248 ◽  
Author(s):  
Mostafa Amr ◽  
Dahoud Raddad ◽  
Fatima El-Mehesh ◽  
Ashraf Bakr ◽  
Khalid Sallam ◽  
...  
Keyword(s):  
Autism Spectrum Disorders ◽  
Psychiatric Disorders ◽  
Children With Autism ◽  
Autism Spectrum ◽  
Arab Children ◽  
Comorbid Psychiatric Disorders ◽  
Spectrum Disorders

scholarly journals International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders

2021 ◽  
Vol 12 ◽  
Author(s):  
Laura Palagini ◽  
Raffaele Manni ◽  
Eugenio Aguglia ◽  
Mario Amore ◽  
Roberto Brugnoli ◽  
...  
Keyword(s):  
Autism Spectrum Disorders ◽  
Psychiatric Disorders ◽  
Mood Disorders ◽  
Sleep Disturbances ◽  
Neuropsychiatric Disorders ◽  
Immediate Release ◽  
Autism Spectrum ◽  
Neurocognitive Disorders ◽  
Prolonged Release ◽  
Spectrum Disorders

Introduction: Insomnia and circadian rhythm disorders, such as the delayed sleep phase syndrome, are frequent in psychiatric disorders and their evaluation and management in early stages should be a priority. The aim of this paper was to express recommendations on the use of exogenous melatonin, which exhibits both chronobiotic and sleep-promoting actions, for the treatment of these sleep disturbances in psychiatric disorders.Methods: To this aim, we conducted a systematic review according to PRISMA on the use of melatonin for the treatment of insomnia and circadian sleep disorders in neuropsychiatry. We expressed recommendations for the use of melatonin in psychiatric clinical practice for each disorder using the RAND/UCLA appropriateness method.Results: We selected 41 studies, which included mood disorders, schizophrenia, substance use disorders, attention deficit hyperactivity disorders, autism spectrum disorders, neurocognitive disorders, and delirium; no studies were found for both anxiety and eating disorders.Conclusion: The administration of prolonged release melatonin at 2–10 mg, 1–2 h before bedtime, might be used in the treatment of insomnia symptoms or comorbid insomnia in mood disorders, schizophrenia, in adults with autism spectrum disorders, neurocognitive disorders and during sedative-hypnotics discontinuation. Immediate release melatonin at <1 mg might be useful in the treatment of circadian sleep disturbances of neuropsychiatric disorders.

Sign in / Sign up

Export Citation Format

Share Document